37 , 38 These proteins may therefore represent novel biomolecular interactions for phthalazinone-based PARP inhibitors, 33 , 34 and engagement of these targets may be significant for the polypharmacology of phthalazinone-based PARP inhibitors in the clinic, leading to deeper understanding of toxicology or novel indications.
← all excerpts
Structure-Guided Design and In-Cell Target Profiling of a Cell-Active Target Engagement Probe for PARP Inhibitors.
1
—
—